News
Because of this flexibility, the 30 to 40 tRNAs present in a cell can "read" all 61 codons in mRNA. The opposite end of the folded structure, which is the 3' end of the tRNA, binds to its ...
The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...
Hosted on MSN16d
New structure gives insight into mRNA export and cancers, and how viruses hijack the process to infect their hostYi Ren's most recent paper, published in eLife, describes the structure of a protein complex involved in mRNA export that sheds light on the underlying molecular mechanism of mRNA export and the ...
The popularity of mRNA-based therapeutics has surged over the past few years. To ensure the safety of these treatments, scientists need to analyze the characteristics of the manufactured molecules, ...
During translation, an mRNA sequence is read using the genetic ... Translation occurs in a structure called the ribosome, which is a factory for the synthesis of proteins. The ribosome has a ...
RNA breaks destined for repair are inflicted by sequence-specific or structure-specific endoribonucleases during physiological RNA processing (e.g. tRNA splicing; kinetoplast mRNA editing) and under ...
These molecules cluster around mitochondria throughout the cytoplasm, forming a structure the team named the mitochondria ... which had been previously associated with oocyte maturation and mRNA ...
They found that mRNA-based COVID-19-vaccinations cause a significant and persistent change through acetylation, i.e., the binding of a chemical group to specific, immunologically relevant genes of ...
Penn Engineers have modified lipid nanoparticles (LNPs)—the revolutionary technology behind the COVID-19 mRNA vaccines—to not only cross the blood-brain barrier (BBB) but also to target specific types ...
RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...
Scientists at Shinshu University School of Medicine have developed a synthetic mRNA that, when injected, revitalizes the immune system to recognize and attack metastasizing cancer cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results